Akiyoshi Shimaya

711 total citations
17 papers, 601 citations indexed

About

Akiyoshi Shimaya is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Akiyoshi Shimaya has authored 17 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Akiyoshi Shimaya's work include Metabolism, Diabetes, and Cancer (9 papers), Adipose Tissue and Metabolism (7 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Akiyoshi Shimaya is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), Adipose Tissue and Metabolism (7 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Akiyoshi Shimaya collaborates with scholars based in Japan, Norway and United States. Akiyoshi Shimaya's co-authors include Masayuki Shibasaki, Hirotsugu Tanaka, Teruhiko Shimokawa, Takeyuki Nagashima, Yasuharu Urano, Nobuharu Shigematsu, Ryosuke Nakano, Eiji Kurosaki, S. Yoshida and Kunizo Arai and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Obesity and Biochemical Pharmacology.

In The Last Decade

Akiyoshi Shimaya

17 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akiyoshi Shimaya Japan 13 420 157 98 94 70 17 601
Chava Harel Israel 12 462 1.1× 272 1.7× 101 1.0× 103 1.1× 151 2.2× 16 724
Zhongmin Alex United States 13 466 1.1× 181 1.2× 207 2.1× 165 1.8× 89 1.3× 14 854
Anne Reifel‐Miller United States 17 487 1.2× 204 1.3× 192 2.0× 117 1.2× 156 2.2× 25 870
Sharon F. Clark Australia 7 719 1.7× 171 1.1× 224 2.3× 77 0.8× 68 1.0× 7 872
Shinsuke Kiritoshi Japan 6 205 0.5× 124 0.8× 61 0.6× 97 1.0× 61 0.9× 6 575
Celia Taha Canada 10 694 1.7× 184 1.2× 174 1.8× 73 0.8× 52 0.7× 10 882
Kazuhiko Nakamaru Japan 5 272 0.6× 114 0.7× 210 2.1× 144 1.5× 75 1.1× 7 556
Jung Ran Kim South Korea 8 250 0.6× 106 0.7× 59 0.6× 67 0.7× 95 1.4× 8 451
Barbara Capuani Italy 13 217 0.5× 138 0.9× 68 0.7× 84 0.9× 70 1.0× 22 488
Tatjana Degenhardt Finland 8 388 0.9× 172 1.1× 44 0.4× 86 0.9× 83 1.2× 11 632

Countries citing papers authored by Akiyoshi Shimaya

Since Specialization
Citations

This map shows the geographic impact of Akiyoshi Shimaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiyoshi Shimaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiyoshi Shimaya more than expected).

Fields of papers citing papers by Akiyoshi Shimaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiyoshi Shimaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiyoshi Shimaya. The network helps show where Akiyoshi Shimaya may publish in the future.

Co-authorship network of co-authors of Akiyoshi Shimaya

This figure shows the co-authorship network connecting the top 25 collaborators of Akiyoshi Shimaya. A scholar is included among the top collaborators of Akiyoshi Shimaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiyoshi Shimaya. Akiyoshi Shimaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tanaka, Hirotsugu, S. Yoshida, Hideaki Minoura, et al.. (2013). Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion. Life Sciences. 94(2). 115–121. 36 indexed citations
2.
Tanaka, Hirotsugu, et al.. (2011). Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist. Life Sciences. 88(11-12). 559–563. 36 indexed citations
3.
Tanaka, Hirotsugu, Takeyuki Nagashima, Akiyoshi Shimaya, et al.. (2010). Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice. European Journal of Pharmacology. 645(1-3). 185–191. 27 indexed citations
4.
Nagashima, Takeyuki, Nobuharu Shigematsu, Yasuharu Urano, et al.. (2010). Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice. Molecular Pharmacology. 78(5). 961–970. 221 indexed citations
5.
Nakano, Ryosuke, et al.. (2006). YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction. European Journal of Pharmacology. 549(1-3). 185–191. 8 indexed citations
6.
Nakano, Ryosuke, Eiji Kurosaki, S. Yoshida, et al.. (2006). Antagonism of peroxisome proliferator-activated receptor γ prevents high-fat diet-induced obesity in vivo. Biochemical Pharmacology. 72(1). 42–52. 59 indexed citations
7.
Nakano, Ryosuke, Eiji Kurosaki, Akiyoshi Shimaya, & Masayuki Shibasaki. (2006). The Novel Hypoglycemic Agent YM440 Improves Hepatic Insulin Resistance in Obese Zucker Fatty Rats. Journal of Pharmacological Sciences. 101(4). 311–317. 5 indexed citations
8.
Shimaya, Akiyoshi, Kristina S. Kovacina, & Richard A. Roth. (2004). On the Mechanism for Neomycin Reversal of Wortmannin Inhibition of Insulin Stimulation of Glucose Uptake. Journal of Biological Chemistry. 279(53). 55277–55282. 23 indexed citations
9.
Kurosaki, Eiji, Ryosuke Nakano, Akiyoshi Shimaya, et al.. (2003). Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor γ and its transactivation. Biochemical Pharmacology. 65(5). 795–805. 13 indexed citations
10.
Kurosaki, Eiji, Ryosuke Nakano, Kazuhiro Momose, et al.. (2003). Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats. European Journal of Pharmacology. 468(2). 151–158. 13 indexed citations
11.
Kurosaki, Eiji, Kazuhiro Momose, Ryosuke Nakano, et al.. (2002). Hypoglycemic Agent YM440 Ameliorates the Impaired Hepatic Glycogenesis After Glucose Loading by Increasing Glycogen Synthase Activity in Obese Zucker Rats. The Japanese Journal of Pharmacology. 89(3). 274–281. 5 indexed citations
12.
Shimaya, Akiyoshi, et al.. (2000). The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice. Metabolism. 49(3). 411–417. 31 indexed citations
13.
Shimaya, Akiyoshi, et al.. (1998). YM268 Increases the Glucose Uptake, Cell Differentiation, and mRNA Expression of Glucose Transporter in 3T3-L1 Adipocytes. Hormone and Metabolic Research. 30(9). 543–548. 37 indexed citations
14.
Shimaya, Akiyoshi, et al.. (1997). Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats. International Journal of Obesity. 21(2). 115–121. 12 indexed citations
15.
Shimaya, Akiyoshi, et al.. (1997). Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats. European Journal of Endocrinology. 137(6). 693–700. 18 indexed citations
16.
Arai, Kunizo, et al.. (1993). Purification and characterization of lysosomal H(+)-ATPase. An anion-sensitive v-type H(+)-ATPase from rat liver lysosomes.. Journal of Biological Chemistry. 268(8). 5649–5660. 53 indexed citations
17.
Hayashi, Hidetoshi, Kunizo Arai, Osamu Sato, et al.. (1992). Three Types of Membranous ATPase on Rat Liver Lysosomes.. Chemical and Pharmaceutical Bulletin. 40(10). 2783–2786. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chava Harel Breakdown of academic impact, for papers by Zhongmin Alex Breakdown of academic impact, for papers by Anne Reifel‐Miller Breakdown of academic impact, for papers by Sharon F. Clark Breakdown of academic impact, for papers by Shinsuke Kiritoshi Breakdown of academic impact, for papers by Celia Taha Breakdown of academic impact, for papers by Kazuhiko Nakamaru Breakdown of academic impact, for papers by Jung Ran Kim Breakdown of academic impact, for papers by Barbara Capuani Breakdown of academic impact, for papers by Tatjana Degenhardt
Rankless by CCL
2026